{name}
{subtitle}
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~5 mi. (Burlington, North Carolina, +822 more cities)
facility
Cone Health Cancer Center at Alamance Regional
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~5 mi. (Burlington, North Carolina, +954 more cities)
facility
Cone Health Cancer Center at Alamance Regional
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
city
~5 mi. (Burlington, North Carolina, +388 more cities)
facility
Cone Health Cancer Center at Alamance Regional
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +2 more types
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
city
~5 mi. (Burlington, North Carolina, +577 more cities)
facility
Cone Health Cancer Center at Alamance Regional
A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioblastoma With Elevated Mutational Burden
city
~5 mi. (Burlington, North Carolina, +263 more cities)
facility
Cone Health Cancer Center at Alamance Regional
drug
ipilimumab, +1 more drug